Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 350 of 520 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/22/14
End: 10/07/19
Due: 10/07/20
Phase: N/A
Priority: Normal
Start: 12/01/21
End: 06/03/26
Due: 06/03/27
Phase: N/A
Priority: Normal
Start: 02/19/13
End: 11/03/20
Due: 11/03/21
Phase: N/A
Priority: Normal
Start: 06/08/17
End: 04/18/22
Due: 04/18/23
Phase: N/A
Priority: Normal
Start: 10/15/15
End: 10/28/21
Due: 10/28/22
Phase: N/A
Priority: Normal
Start: 05/05/17
End: 10/17/17
Due: 10/17/18
Phase: N/A
Priority: Normal
Start: 02/16/17
End: 09/07/21
Due: 09/07/22
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 04/01/23
Due: 04/01/24
Phase: N/A
Priority: Normal
Start: 05/25/23
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 01/11/23
End: 02/28/27
Due: 02/28/28
Phase: N/A
Priority: Normal
Start: 02/22/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/25/23
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 05/05/20
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 10/27/20
End: 07/26/23
Due: 07/26/24
Phase: N/A
Priority: Normal
Start: 08/31/25
End: 03/31/30
Due: 03/31/31
Phase: N/A
Priority: Normal
Start: 11/29/22
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 06/30/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/00
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 10/31/12
Due: 10/31/13
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
Phase: N/A
Priority: Normal
Start: 01/12/24
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 07/31/99
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 08/28/19
End: 09/01/25
Due: 09/01/26
Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 06/30/16
Due: 06/30/17